Skip to main content
. 2023 Oct 5;3:135. doi: 10.1038/s43856-023-00371-0

Table 2.

Oral pharmacological agent adequate to achieve target glucose levels vs need for escalation to insulin to achieve glucose targets.

Precision Marker Studies Participants Statistical method Effect Estimate (95%CI) GRADE
Age (years) 11 1473 Mean difference (95%CI) −1.04 [−2.10, 0.03] ⊕⊕◯◯
Nulliparity 8 1215 Odds Ratio (95%CI) 1.55 [1.17, 2.04] ⊕⊕◯◯
Body mass index (kg/m2) 10 1692 Mean difference (95%CI) −1.21 [−2.21, −0.21] ⊕⊕◯◯
Previous history of GDM 8 1412 Odds Ratio (95%CI) 0.43 [0.30, 0.63] ⊕⊕◯◯
Haemoglobin A1C (%) 6 1152 Mean difference (95%CI) −0.21 [−0.29, −0.13] ⊕⊕◯◯
Fasting glucose (mg/dl) 12 1836 Mean difference (95%CI) −8.02 [−11.87, −4.16] ⊕◯◯◯
1-h glucose (mg/dl) 8 1177 Mean difference (95%CI) −10.64 [−18.25, −3.02] ⊕◯◯◯
2-h glucose (mg/dl) 10 1378 Mean difference (95%CI) −7.31 [−11.38, −3.25] ⊕◯◯◯
3-h glucose (mg/dl) 6 679 Mean difference (95%CI) 0.00 [−11.79, 11.79] ⊕◯◯◯
Family history of diabetes 6 1040 Odds Ratio (95%CI) 0.79 [0.50, 1.25] ⊕⊕◯◯
Gestational age at GDM diagnosis (weeks) 11 1473 Mean difference (95%CI) 2.64 [1.42, 3.86] ⊕⊕◯◯
Gestation at oral pharmacological agent initiation (weeks) 7 967 Mean difference (95%CI) 3.79 [2.08, 5.51] ⊕⊕◯◯

Very low ⊕◯◯◯.

Low ⊕⊕◯◯.